Mc Elhenny Sheffield Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Mc Elhenny Sheffield Capital Management, LLC

  • $289 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 11, 2023
BUY
$62.39 - $113.8 $1,060 - $1,934
17 New
17 $0
Q2 2022

Jul 22, 2022
SELL
$79.4 - $116.36 $794,000 - $1.16 Million
-10,000 Closed
0 $0
Q1 2022

Apr 20, 2022
SELL
$86.42 - $109.81 $51,852 - $65,886
-600 Reduced 5.66%
10,000 $1.05 Million
Q4 2021

Jan 12, 2022
BUY
$98.56 - $119.91 $1.04 Million - $1.27 Million
10,600 New
10,600 $1.14 Million

Others Institutions Holding HZNP

# of Institutions
39
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Mc Elhenny Sheffield Capital Management, LLC Portfolio

Follow Mc Elhenny Sheffield Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Elhenny Sheffield Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Elhenny Sheffield Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email